These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10408707)

  • 21. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
    Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
    BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
    Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
    Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.
    Tørring N; Borre M; Sørensen KD; Andersen CL; Wiuf C; Ørntoft TF
    Br J Cancer; 2007 Feb; 96(3):499-506. PubMed ID: 17245344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer.
    Li C; Berx G; Larsson C; Auer G; Aspenblad U; Pan Y; Sundelin B; Ekman P; Nordenskjöld M; van Roy F; Bergerheim US
    Genes Chromosomes Cancer; 1999 Mar; 24(3):175-82. PubMed ID: 10451696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma.
    Godfrey TE; Cher ML; Chhabra V; Jensen RH
    Cancer Genet Cytogenet; 1997 Oct; 98(1):36-42. PubMed ID: 9309116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer.
    Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H
    Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis.
    Wittmann S; Zirn B; Alkassar M; Ambros P; Graf N; Gessler M
    Genes Chromosomes Cancer; 2007 Feb; 46(2):163-70. PubMed ID: 17099873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
    Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
    Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion at chromosome arms 6q16-22 and 10q22.3-23.1 associated with initiation of prostate cancer.
    Lu T; Hano H
    Prostate Cancer Prostatic Dis; 2008; 11(4):357-61. PubMed ID: 18227855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome 16 allelic loss analysis of a large set of microdissected prostate carcinomas.
    Strup SE; Pozzatti RO; Florence CD; Emmert-Buck MR; Duray PH; Liotta LA; Bostwick DG; Linehan WM; Vocke CD
    J Urol; 1999 Aug; 162(2):590-4. PubMed ID: 10411092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer.
    Utada Y; Emi M; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Haga S; Kajiwara T; Nakamura Y
    Clin Cancer Res; 2000 Aug; 6(8):3193-8. PubMed ID: 10955803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.